Maki Hisataka | Department Of Cardiovascular Medicine Graduate School Of Medicine University Of Tokyo

スポンサーリンク

概要

関連著者

もっと見る

著作論文

Initial and Programmed Combination Therapy With Oral Drugs for Severe Idiopathic Pulmonary Arterial Hypertension
Novel Risk Scoring System With Preoperative Objective Parameters Gives a Good Prediction of 1-Year Mortality in Patients With a Left Ventricular Assist Device
A case of late-onset right ventricular failure after implantation of a continuous-flow left ventricular assist device
Volumetric and Functional Assessment of Ventricles in Pulmonary Hypertension on 3-Dimensional Echocardiography
Novel Criteria of Urine Osmolality Effectively Predict Response to Tolvaptan in Decompensated Heart Failure Patients
Successful Conversion to Everolimus After Cytomegalovirus Infection in a Heart Transplant Recipient
Trend of Clinical Outcome and Surrogate Markers During Titration of β-Blocker in Heart Failure Patients With Reduced Ejection Fraction : – Relevance of Achieved Heart Rate and β-Blocker Dose –
Preoperative Levels of Bilirubin or Creatinine Adjusted by Age Can Predict Their Reversibility After Implantation of Left Ventricular Assist Device
Rapidly Progressive Cardiac Allograft Vasculopathy in Early Onset Regressed With Everolimus Treatment in an Adult Cardiac Recipient
Correction of Hyponatremia by Tolvaptan Before Left Ventricular Assist Device Implantation
Early decision for a left ventricular assist device implantation is necessary for patients with modifier A
A Case of Pancreatic Cancer After Heart Transplantation
Combination Evaluation of Preoperative Risk Indices Predicts Requirement of Biventricular Assist Device
Successful Conversion From Thiazide to Tolvaptan in a Patient With Stage D Heart Failure and Chronic Kidney Disease Before Heart Transplantation
Everolimus-Incorporated Immunosuppressant Strategy Improves Renal Dysfunction While Maintaining Low Rejection Rates After Heart Transplantation in Japanese Patients
A Case With Recovery of Response to Tolvaptan Associated With Remission of Acute Kidney Injury and Increased Urine Osmolality
Urine Osmolality Estimated Using Urine Urea Nitrogen, Sodium and Creatinine Can Effectively Predict Response to Tolvaptan in Decompensated Heart Failure Patients
Volumetric and Functional Assessment of Ventricles in Pulmonary Hypertension on 3-Dimensional Echocardiography
Preoperative Levels of Bilirubin or Creatinine Adjusted by Age Can Predict Their Reversibility After Implantation of Left Ventricular Assist Device
Insufficient Self-Care Is an Independent Risk Factor for Adverse Clinical Outcomes in Japanese Patients With Heart Failure
Tolvaptan Can Improve Clinical Course in Responders:Validation Analysis for the Definition of Responsiveness by Urine Volume
How to demonstrate the reversibility of end-organ function before implantation of left ventricular assist device in INTERMACS profile 2 patients?
Trend of Clinical Outcome and Surrogate Markers During Titration of β-Bloeker in Heart Failure Patients With Reduced Ejection Fraction : Relevance of Achieved Heart Rate and β-Blocker Dose
Novel Criteria of Urine Osmolality Effectively Predict Response to Tolvaptan in Decompensated Heart Failure Patients : Association Between Non-Responders and Chronic Kidney Disease
Urine Osmolality Estimated Using Urine Urea Nitrogen, Sodium and Creatinine Can Effectively Predict Response to Tolvaptan in Decompensated Heart Failure Patients
Low Cardiac Output Stimulates Vasopressin Release in Patients With Stage D Heart Failure:– Its Relevance to Poor Prognosis and Reversal by Surgical Treatment –
Increased Urine Aquaporin-2 Relative to Plasma Arginine Vasopressin Is a Novel Marker of Response to Tolvaptan in Patients With Decompensated Heart Failure
Recipients With Shorter Cardiopulmonary Bypass Time Achieve Improvement of Parasympathetic Reinnervation Within 6 Months After Heart Transplantation

もっと見る

スポンサーリンク